Concepedia

Publication | Open Access

An orally active small molecule TGF-beta receptor I antagonist inhibits the growth of metastatic murine breast cancer.

42

Citations

28

References

2009

Year

Abstract

Taken together, the data indicate that the antitumor efficacy of SM16 is dependent on an immune-mediated mechanism and that SM16 may represent a safe and effective treatment for metastatic breast cancer.

References

YearCitations

Page 1